Seer, Thermo Fisher enter co-marketing and sales agreement

Seer (SEER) announced a co-marketing and sales agreement with Thermo Fisher (TMO) to jointly promote Seer’s Proteograph Product Suite alongside Thermo Scientific Orbitrap Astral mass spectrometers. This strategic collaboration aims to accelerate the adoption of innovative proteomic technologies, offering researchers an integrated solution for deep, rapid, and unbiased proteomic analysis at scale. Under this non-exclusive agreement, Thermo Fisher’s global sales force will have the ability to quote and sell Seer’s Proteograph Product Suite, which includes an automation instrument, proprietary engineered nanoparticles, and software analysis suite. The integration is set to commence in early 2025. The collaboration will also enable Seer and Thermo Fisher to conduct joint marketing activities, including conference promotions, seminars, and webinars, to showcase the combined power of their proteomic platforms.